Acumen Pharmaceuticals, Inc. (ABOS) Social Stream
ACUMEN PHARMACEUTICALS INC (ABOS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ACUMEN PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-17 | 3 | $27 | $20 | $24.666 | $5.25 | 369.83% |
| 2021-11-19 | 3 | $27 | $16 | $23.333 | $5.25 | 344.44% |
| 2022-01-21 | 3 | $27 | $14 | $22.666 | $5.25 | 331.73% |
| 2022-03-07 | 3 | $27 | $14 | $19.333 | $5.25 | 268.25% |
| 2022-05-27 | 3 | $27 | $9 | $17.666 | $5.25 | 236.5% |
| 2022-07-15 | 5 | $17 | $9 | $14 | $5.25 | 166.67% |
| 2022-08-13 | 3 | $17 | $9 | $14 | $5.25 | 166.67% |
| 2022-11-18 | 4 | $22 | $9 | $15.75 | $5.25 | 200% |
| 2023-03-28 | 4 | $22.001 | $9 | $15.75 | $5.25 | 200% |
| 2023-05-12 | 4 | $22.001 | $9 | $15 | $5.25 | 185.71% |
| 2023-05-18 | 5 | $22.001 | $9 | $14.6 | $5.25 | 178.1% |
The Trend in the Analyst Price Target
ABOS's average price target has moved down $1.15 over the prior 99 days.
Over the past 51 weeks, ABOS's average upside potential has been 171.13%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-27 | 3 | 27.000 | 9 | 17.666 | 3.56 | 396.24% |
| 2022-11-18 | 3 | 22.001 | 9 | 15.750 | 6.08 | 159.05% |
| 2023-03-28 | 4 | 22.001 | 9 | 15.000 | 4.01 | 274.06% |
| 2023-03-28 | 4 | 22.001 | 9 | 15.750 | 4.01 | 292.77% |
| 2023-05-10 | 4 | 22.001 | 9 | 15.000 | 6.59 | 127.62% |
ABOS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
ABOS's average broker recommendation rating improved by 0 over the prior 14 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, ACUMEN PHARMACEUTICALS INC's number of analysts covering the stock is greater than 165.67% of them.
- ACUMEN PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1117.56% of all US stocks.
- In the context of all US stocks, ACUMEN PHARMACEUTICALS INC's average analyst price target is greater than 280.28% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ACUMEN PHARMACEUTICALS INC's variance in analysts' estimates is lower than -799.01% of them.
In the Pharmaceutical Products industry, SOPH, CADL, and ICVX are the three stocks most similar to ACUMEN PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ABOS a Buy, Hold or Sell? See the POWR Ratings now!